Michael Roche

1.9k total citations
52 papers, 1.3k citations indexed

About

Michael Roche is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Michael Roche has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Virology, 29 papers in Infectious Diseases and 16 papers in Immunology. Recurrent topics in Michael Roche's work include HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (17 papers). Michael Roche is often cited by papers focused on HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (17 papers). Michael Roche collaborates with scholars based in Australia, United States and Denmark. Michael Roche's co-authors include Melissa J. Churchill, Paul R. Gorry, Lachlan Gray, Anne Ellett, Steve Wesselingh, Sharon R. Lewin, Jacqueline K. Flynn, Jasminka Sterjovski, Anthony L. Cunningham and Paul A. Ramsland and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Annals of Neurology.

In The Last Decade

Michael Roche

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Roche Australia 23 1.0k 560 407 253 196 52 1.3k
Vanessa Pirrone United States 20 628 0.6× 366 0.7× 151 0.4× 382 1.5× 213 1.1× 49 1.1k
Wei Chao United States 24 1.2k 1.2× 413 0.7× 410 1.0× 382 1.5× 309 1.6× 39 1.6k
Benjamin G. Luttge United States 12 580 0.6× 266 0.5× 243 0.6× 272 1.1× 191 1.0× 16 897
Gretja Schnell United States 22 855 0.8× 914 1.6× 267 0.7× 150 0.6× 919 4.7× 43 1.9k
Zhaohao Liao United States 14 588 0.6× 292 0.5× 344 0.8× 648 2.6× 187 1.0× 26 1.3k
Jodi Anderson United States 16 735 0.7× 496 0.9× 372 0.9× 230 0.9× 269 1.4× 28 1.3k
Virginie Gautier Ireland 15 459 0.4× 218 0.4× 247 0.6× 414 1.6× 95 0.5× 34 893
Jianglin He United States 6 777 0.8× 249 0.4× 578 1.4× 314 1.2× 162 0.8× 7 1.3k
Jerome H. Kim United States 12 698 0.7× 495 0.9× 98 0.2× 95 0.4× 211 1.1× 24 852
Carolina Gutiérrez Spain 16 586 0.6× 456 0.8× 195 0.5× 152 0.6× 216 1.1× 33 919

Countries citing papers authored by Michael Roche

Since Specialization
Citations

This map shows the geographic impact of Michael Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roche more than expected).

Fields of papers citing papers by Michael Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roche. The network helps show where Michael Roche may publish in the future.

Co-authorship network of co-authors of Michael Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Roche. A scholar is included among the top collaborators of Michael Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Roche. Michael Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jingling, Narin Osman, Trisha A. Jenkins, et al.. (2025). Neuroinflammation associated with proviral DNA persists in the brain of virally suppressed people with HIV. Frontiers in Immunology. 16. 1570692–1570692.
2.
Angelovich, Thomas A., Jingling Zhou, Carolin Tumpach, et al.. (2024). HIV transcription persists in the brain of virally suppressed people with HIV. PLoS Pathogens. 20(8). e1012446–e1012446. 6 indexed citations
3.
Tumpach, Carolin, Ajantha Rhodes, Youry Kim, et al.. (2023). Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA. Viruses. 15(7). 1606–1606. 10 indexed citations
4.
Busman‐Sahay, Kathleen, Thomas A. Angelovich, Michael Nekorchuk, et al.. (2023). Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques. PLoS Pathogens. 19(3). e1011290–e1011290. 9 indexed citations
5.
Tumpach, Carolin, Catherine R. Cochrane, Youry Kim, et al.. (2023). Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform. Journal of Virus Eradication. 9(2). 100335–100335. 11 indexed citations
6.
Zerbato, Jennifer M., Anchalee Avihingsanon, Kasha P. Singh, et al.. (2022). HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy. EBioMedicine. 87. 104391–104391. 18 indexed citations
7.
Cochrane, Catherine R., Thomas A. Angelovich, Jingling Zhou, et al.. (2022). Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART. Annals of Neurology. 92(4). 532–544. 49 indexed citations
8.
9.
Zerbato, Jennifer M., Georges Khoury, Wei Zhao, et al.. (2021). Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency. EBioMedicine. 65. 103241–103241. 25 indexed citations
10.
Fichter, Christina, Anupriya Aggarwal, Melissa J. Churchill, et al.. (2021). Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells. Viruses. 13(6). 1170–1170. 6 indexed citations
11.
Cochrane, Catherine R., Michael Roche, Jacob D. Estes, et al.. (2021). The role of oxidative stress in HIV-associated neurocognitive disorders. Brain Behavior & Immunity - Health. 13. 100235–100235. 37 indexed citations
12.
Gartner, Matthew J., Michael Roche, Melissa J. Churchill, Paul R. Gorry, & Jacqueline K. Flynn. (2020). Understanding the mechanisms driving the spread of subtype C HIV-1. EBioMedicine. 53. 102682–102682. 55 indexed citations
13.
Gartner, Matthew J., Paul R. Gorry, Carolin Tumpach, et al.. (2020). Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection. Retrovirology. 17(1). 24–24. 2 indexed citations
14.
Xu, Yin, Chansavath Phetsouphanh, Kazuo Suzuki, et al.. (2017). HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells. Frontiers in Immunology. 8. 376–376. 23 indexed citations
15.
Flynn, Jacqueline K., Paula Ellenberg, Renee C. Duncan, et al.. (2017). Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists. AIDS Research and Human Retroviruses. 33(12). 1220–1235. 6 indexed citations
16.
Roche, Michael, et al.. (2015). Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes. Current Topics in Medicinal Chemistry. 16(10). 1091–1106. 9 indexed citations
17.
Gray, Lachlan, Michael Roche, Jacqueline K. Flynn, et al.. (2014). Is the central nervous system a reservoir of HIV-1?. Current Opinion in HIV and AIDS. 9(6). 552–558. 94 indexed citations
18.
Jones, Kate, Michael Roche, Michael P. Gantier, et al.. (2010). X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells. Journal of Biological Chemistry. 285(24). 18603–18614. 26 indexed citations
19.
Sterjovski, Jasminka, Lachlan Gray, Michael Roche, et al.. (2009). Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection. Virology. 396(2). 246–255. 18 indexed citations
20.
Sterjovski, Jasminka, Melissa J. Churchill, Anne Ellett, et al.. (2007). Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Retrovirology. 4(1). 89–89. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanessa Pirrone Breakdown of academic impact, for papers by Wei Chao Breakdown of academic impact, for papers by Benjamin G. Luttge Breakdown of academic impact, for papers by Gretja Schnell Breakdown of academic impact, for papers by Zhaohao Liao Breakdown of academic impact, for papers by Jodi Anderson Breakdown of academic impact, for papers by Virginie Gautier Breakdown of academic impact, for papers by Jianglin He Breakdown of academic impact, for papers by Jerome H. Kim Breakdown of academic impact, for papers by Carolina Gutiérrez
Rankless by CCL
2026